In AD patients without past stroke lesions, plasma NfL levels may suggest the severity of cognitive impairment, and the plasma Aβ42/Aβ40 ratio may correlate with the severity of depression as neuropsychological symptoms. This evidence concerns the gene NEFL and depressive symptom measurement.